Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,691 annual reports · 4,011 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 490 of 641 · 7,691 filings

  • Nlight (LASR) FY2024 10-K risk factors
    37 risks

    Aerospace and defense market reliance on government budgets dominates our operating risks. Customer concentration and high fixed manufacturing costs pose significant ongoing threats. Intellectual property and complex global export controls threaten competitive positioning.

    Filed Feb 28, 2025
  • Ligand Pharmaceuticals (LGND) FY2024 10-K risk factors
    49 risks

    Ligand relies heavily on royalty and material revenues from key partnered products like Kyprolis and Captisol.

    Filed Feb 28, 2025
  • Longeveron (LGVN) FY2024 10-K risk factors
    92 risks

    Longeveron relies on unproven stem cell technologies with no approved products and ongoing going concern uncertainty.

    Filed Feb 28, 2025
  • Lindblad Expeditions Holdings (LIND) FY2024 10-K risk factors
    51 risks

    Lindblad Expeditions relies heavily on its brand partnerships with National Geographic and World Wildlife Fund for marketing and conservation travel offerings. The company operates in a capital-intensive industry with significant debt obligations totaling $635.0 million as of December 2024. Operations are vulnerable to environmental disruptions, regulatory restrictions in key destinations like the Galápagos, and fluctuations in global travel demand.

    Filed Feb 28, 2025
  • Lemaitre Vascular (LMAT) FY2024 10-K risk factors
    39 risks

    Risk section dominated by acquisition strategy reliance, reliance on sole-source biologic suppliers like XenoSure, and heavy regulatory oversight.

    Filed Feb 28, 2025
  • Macerich (MAC) FY2024 10-K risk factors
    37 risks

    Macerich relies heavily on shopping centers concentrated in California, New York, and Arizona, facing significant retail and debt refinancing pressures.

    Filed Feb 28, 2025
  • Matson (MATX) FY2024 10-K risk factors
    31 risks

    Matson faces heavy regulatory dependency on the Jones Act for its domestic shipping operations in Hawaii and Alaska. Fleet operations are exposed to fuel price volatility, vessel construction timelines, and environmental compliance costs. Capital structure and labor agreements present ongoing financial and operational constraints.

    Filed Feb 28, 2025
  • Merchants Bancorp (MBIN) FY2024 10-K risk factors
    45 risks

    Merchants Bancorp faces primary risks from interest rate fluctuations impacting its extensive mortgage banking and warehouse financing operations. Asset quality risks tied to real estate construction and multi-family loans dominate the credit portfolio. Regulatory scrutiny and compliance costs remain high as assets exceed the $10 billion threshold.

    Filed Feb 28, 2025
  • Metropolitan Bank Holding (MCB) FY2024 10-K risk factors
    37 risks

    Substantial concentration in commercial real estate and commercial loans totaling $5.9 billion or 98.3% of total loans.

    Filed Feb 28, 2025
  • Marcus (MCS) FY2024 10-K risk factors
    28 risks

    Marcus Corp's risks center on its two core divisions, movie theatres and hotels, exposed to industry trends, weather, and labor costs.

    Filed Feb 28, 2025
  • Monster Beverage (MNST) FY2024 10-K risk factors
    39 risks

    Monster Beverage relies heavily on TCCC for distribution and on third-party contract packers for manufacturing most finished goods.

    Filed Feb 28, 2025
  • Morningstar (MORN) FY2024 10-K risk factors
    24 risks

    Morningstar faces intense risks regarding its research independence, regulatory compliance across global markets, and data/cybersecurity protection.

    Filed Feb 28, 2025

Companies covered

4,011 companies

371 more under A